Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Sio Gene Therapies Inc. (AXON)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsMar-31-22Mar-31-21Mar-31-20Mar-31-19Mar-31-18Mar-31-17Mar-31-16
   10-K10-K10-K10-K10-K10-K10-K
Revenues  -0.19.6-3.0-1.9-7.3-1.50.0
            Revenue growth  -100.7%-416.7%57.7%-73.9%385.1%  
Cost of goods sold  0.00.00.00.00.00.00.0
Gross profit  -0.19.6-3.0-1.9-7.3-1.50.0
            Gross margin  100.0%100.0%100.0%100.0%100.0%100.0% 
Selling, general and administrative   [+]18.217.322.139.571.945.756.5
Research and development  53.424.947.187.6141.4134.876.6
EBITDA   [+]-71.4-31.7-70.7-126.5-217.6-181.8-133.1
            EBITDA margin  108121.2%-331.5%2342.3%6608.3%2966.6%12021.3% 
Depreciation and amortization  0.30.91.52.53.10.20.0
EBIT   [+]-71.6-32.6-72.2-128.9-220.7-182.0-133.2
            EBIT margin  108527.3%-341.4%2391.2%6736.3%3008.6%12037.8% 
Interest expense  0.00.84.47.57.51.1 
Other income (expense), net   [+]0.00.84.47.57.51.1 
Pre-tax income  -71.6-32.6-72.2-128.9-220.7-182.0-133.2
Income taxes  0.3-0.20.40.10.9-1.10.0
            Tax rate   0.6%   0.6%0.0%
Net income  -71.9-32.4-72.6-129.1-221.6-181.0-133.1
            Net margin  108939.4%-338.9%2404.8%6743.2%3021.2%11967.7% 
   
Basic EPS   [+]($0.98)($0.62)($2.93)($8.02)($16.51)($1.82)($1.41)
Diluted EPS   [+]($0.98)($0.62)($2.93)($8.02)($16.51)($1.82)($1.41)
   
Shares outstanding (basic)   [+]73.252.224.816.113.499.294.5
Shares outstanding (diluted)   [+]73.252.224.816.113.499.294.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy